Leonardo DRS Reports Strong Q1 Results, Beats Expectations, and Raises Full-Year Guidance

summarizeSummary

Leonardo DRS reported better-than-expected first-quarter results with significant growth in revenue and profitability, leading to an upward revision of its full-year guidance.

check_boxKey Events

• Strong First Quarter Financial Performance

  Leonardo DRS reported Q1 2026 revenue of $846 million (up 6% year-over-year), net earnings of $62 million (up 24% year-over-year), and Adjusted EBITDA of $105 million (up 28% year-over-year). Diluted EPS increased 21% to $0.23, and Adjusted Diluted EPS rose 30% to $0.26.

• Raised Full-Year 2026 Guidance

  The company increased its full-year 2026 guidance for revenue to $3,900 million - $3,975 million (from $3,850 million - $3,950 million), Adjusted EBITDA to $515 million - $530 million (from $505 million - $525 million), and Adjusted Diluted EPS to $1.26 - $1.30 (from $1.20 - $1.26).

• Dividend Declared

  The Board of Directors declared a cash dividend of $0.09 per share of common stock, payable on June 2, 2026.

• Share Repurchase Program Activity

  During the first quarter, the company repurchased 91,238 shares of its common stock for approximately $4 million under its previously announced stock repurchase program.

auto_awesomeAnalysis

Leonardo DRS delivered a strong first quarter, significantly outperforming expectations across key financial metrics. The company reported substantial year-over-year growth in revenue, net earnings, and Adjusted EBITDA, driven by disciplined execution and program momentum. This robust performance has led management to raise its full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted Diluted EPS, signaling an improved outlook for the remainder of the year. Additionally, the declaration of a cash dividend and ongoing share repurchases underscore the company's financial health and commitment to returning capital to shareholders. This filing provides a strong positive signal regarding the company's operational strength and future prospects.